Cellphmed is a bioinformatic platform enabling the discovery and early development of novel diagnostic biomarkers and immunotherapy targets to better treat cancer. Having developed proprietary tools to decipher unexplored regions of the genome (up to 80% encompassing millions of uncharted RNA biomarkers) the company’s vision is to use big data to change the paradigm of oncology in providing the right drug to the right patient at the right time, thereby bringing personalized medicine to the clinic.